IHS Chemical Week

Regions :: Western Europe :: Germany

Secondary Buyout for Specialty Firm

12:32 PM MDT | July 23, 2007 | Chemical Week Editorial Staff

Axa Private Equity (Paris) has acquired more than 70% of specialty chemicals producer Cabb (Sulzbach, Germany) from private equity firm Gilde (Utrecht, the Netherlands). The rest is held by Cabb’s management. Cabb makes monochloroacetic acid and a range of specialty intermediates, and has sales of €140 million/year ($182 million). Its production is at Gersthofen and Knapsack, Germany. Gilde bought the business from Clariant in 2005. Cabb is Axa’s second specialties acquisition in the space of six months following the purchase of Eliokem...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers




contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa